DOPA-Kiss was initiated in 01/09/2023. The workplan has been conducted as originally planned, it being implemented in three connected work packages (WP), which have all progressed efficiently. The sections below show the work performed and main achievements for each WP.
WP1: Characterization of the hypothalamic metabolomic landscape and transcriptomic profiles of Kiss1 neuronal populations at pubertal maturation and conditions of early-onset obesity using multi-omic techniques.
Models of early-onset obesity with alterations of pubertal timing have been developed in female rats and in male and female mice, and we have completed large-scale lipidomic analyses of the mediobasal hypothalamus in the female rat model. We have generated suitable mouse lines to allow separation of Kiss1 neurons in models of early-onset obesity, implemented in juvenile and pubertal male and female mice, both under normal nutrition and obesity. We have conducted RNAseq analyses of these neuronal populations followed by in depth bioinformatic analyses. Finally, we have carried out initial spatial transcriptomic analyses in hypothalamic tissue sections form juvenile and peripubertal female mice, under control nutrition or obesity, and are optimizing protocols for bioinformatic analysis of these large datasets.
WP2: Characterization of novel mechanisms of metabolic and nutrient sensing in Kiss1 neurons and related pathways, as major determinants for obesity-induced perturbed puberty.
We have completed a study addressing the role of novel lipid sensing mechanisms at the hypothalamus in the control of puberty and its alterations in conditions of early obesity. This study is being complemented with additional analyses addressing the role of hypothalamic ER stress in the control of puberty and its perturbations in early obesity. Altogether, these data point out changes in the expression profiles of components of lipid sensing pathways and their contribution to the control of puberty in conditions of normal nutrition and obesity. Changes in ER stress are likely involved also in pubertal alterations bound to obesity, in a mechanism converging at the hypothalamic arcuate nucleus and potentially involving Kiss1 neurons.
WP3: Dissection of the molecular basis of the metabolic control of puberty by applying genome editing of Kiss1 neurons in vivo, using conventional and CRISPR-Cas9 based functional genomics.
Progression of WP3 is subordinated to that of WP1-2. Yet, we have already conducted activities for in vivo gene editing/ablation of suspected key factors in pubertal control, paving the way for additional analyses during the next 3 years. As most salient result so far, we have used functional genomics in the context of our studies to address the putative roles of kisspeptin signaling in key non-neuronal cells involved in pubertal control, namely, astrocytes. These analyses, which have been published recently, documented for the first time the putative role of kisspeptin actions in astrocytes as component for female pubertal acceleration in conditions of early obesity.